Salta al contenuto principale

Per favore
selezionare il paese

Attenzione, le pagine di questa sezione sono disponibili solo in lingua inglese.

Selezionando la vista Internazionale, confermi di risiedere al di fuori degli Stati Uniti e di voler visualizzare le Informazioni sui prodotti Diasorin internazionali.
Questo materiale è destinato esclusivamente ai visitatori internazionali (non statunitensi) del sito.

Pursuant to the Guidelines of the Ministry of Health dated 28/03/2013 related to health advertising concerning medical devices, in vitro diagnostic medical devices and medical-surgical devices, we hereby inform you that the information contained in this website and to which you are going to access is exclusively intended for professional operators.

Simplexa® COVID-19/ Flu A/B & RSV Direct

Differential Identification of the Most Prevalent Respiratory Viruses in One Test

A real-time RT-PCR assay enabling the differential detection of SARS-CoV-2, influenza A, influenza B, and RSV within the same reaction using a single sample.

Simplexa<sup>®</sup> COVID-19/ Flu A/B  & RSV Direct

Disease state

Differential diagnosis of flu, COVID-19, and respiratory syncytial virus (RSV), especially during respiratory virus season, is essential for effective infection control and patient management. Co-infections involving SARS-CoV-2, influenza A and B viruses, and RSV have been reported, making accurate diagnosis more challenging; since these viruses share overlapping clinical symptoms, they can be difficult to distinguish based on presentation alone.

The 4 most relevant seasonal respiratory viruses: SARS-CoV-2, Flu A, Flu B, and RSV

The value of Simplexa® COVID-19/ Flu A/B & RSV Direct

The newest member of the ever-expanding LIAISON® MDX testing portfolio

Fast time-to-result

Moderate complexity, sample-to-answer system with no RNA extraction and all-in-one reagents for use on anterior nasal swabs and nasopharyngeal swabs with results in under an hour.

Meets the needs of the post-pandemic respiratory landscape

RT-PCR assay enabling differential diagnosis of COVID-19, influenza A, influenza B, and RSV from the same sample in the same well.

Performance you need

Sensitive and specific clinical detection across all targets observed within a multiplex assay.

How Simplexa® COVID-19/ Flu A/B & RSV Direct works

Simplexa® COVID-19 / Flu A/B & RSV Direct is an in-vitro qualitative real-time RT-PCR assay with a simple workflow, enabling unextracted primary sample and ready-to-use PCR reagent loading on a re-usable Direct Amplification Disc on the compact LIAISON® MDX system designed for operational simplicity, flexibility, and quality assurance for utility across any clinical lab.

01

Sample-to-answer

Scan 1–8 primary unextracted samples per run, ready-to-use single-use reaction mix vials, and the 8-well Direct Amplification Disc. Simply load samples and reagents directly onto the disc, place the disc on the LIAISON® MDX instrument, and press run for results in under 60 minutes.

02

Intuitive LIAISON® MDX Studio Software

Integrated QC checks and reporting for individual assays or use the multi-assay suite feature for compatible assays. View PCR curves and QC charts, Interface with LIS, and even access software during runs.

Indications for Simplexa® COVID-19/ Flu A/B & RSV Direct use

Assay and system

A real-time RT-PCR assay run on LIAISON® MDX to detect SARS-CoV-2, Flu A, Flu B, & RSV in one sample.

Patient types

Human patients with signs and symptoms of respiratory tract infection.

Diagnostic Lab

Hospital, Commercial, Reference, and Public Health laboratories.

Simplexa® COVID-19/ Flu A/B & RSV Direct workflow

Scan, load, and go

Ready to use

  • No prep & No waste
  • Single-use reagents (24 reactions)
  • No mixing, pouring, or rehydrating

Simple & easy workflow

  • No extraction needed, direct sample input
  • Liquid sensor to ensure adequate sample volume metered: No precise pipetting required
  • CLIA Moderate Complexity
01

Scan

  • Scan the assay definition QR code (upon first use only)
  • Scan the lot-specific QR code on a vial or card
  • Scan the disc barcode
  • Scan the sample barcode
02

Load

In each Disc Wedge:

  • Load 50 µl of sample
  • Load 50 µl of reaction mix
  • Close the foil and remove the tab
  • Load the disc onto the LIAISON® MDX.
03

Run

Start the run. The results and a final report are automatically generated by the software.

  • Disc may be re-used up to 8 times (until all wedges are utilized)

To be used on the LIAISON® MDX Instrument

The LIAISON® MDX is an innovative and powerful real-time PCR instrument with two consumable disc options: the 8-well Direct Amplification Disc and the 96-well Universal Disc for higher volume testing.

Supported by an expanding menu of molecular assays, the system provides easy-to-understand results with the ability to check amplification curves after a run. These expansive capabilities come with a compact footprint measuring only 12″ by 8″ by 12″ so that it can fit into laboratories of any size.

LIAISON® MDX - Strumento di Diagnostica Molecolare - Diasorin

LIAISON® MDX

One instrument.
Multiple discs.
Ultimate Flexibility.

Discover more

Simplexa® COVID-19/ Flu A/B & RSV Direct ordering info

Part Name
Kit Size
Registration Status
Part Number

Simplexa® COVID-19/ Flu A/B & RSV Direct

24

IVD

MOL4450

Simplexa® COVID-19/ Flu A/B & RSV Direct Positive Control Pack

10

IVD

MOL4460

Resources

Diasorin document repository

Dialog

Luminex document repository

Discover more

Research publications

Discover more

More details about Simplexa® COVID-19/ Flu A/B & RSV Direct

Get in touch

If you need any information about our products, contact our specialists. 

Contact us

Need any help?

Get help with Diasorin products and services.

Ask for support